Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. They can range from 2 to 50 amino acids in length. There are two main types of peptides: linear peptides, which contain amino acids linked end-to-end in a chain, and cyclic peptides, which form a ring structure with their amino and carboxyl termini connected via a peptide bond. Peptides serve various important biological functions and pharmaceutical applications.

There are mainly solid-phase and liquid-phase peptide synthesis methods. Solid-phase peptide synthesis is the most commonly used method, as it allows easy purification and produces higher yields compared to liquid-phase synthesis. In the solid phase, the first amino acid is attached to an insoluble polymer support. Subsequent amino acids are then added step-by-step to grow the peptide chain. The peptide is then cleaved off the resin support and can be easily purified. Cyclic peptides pose additional challenges for synthesis and require methods like native chemical ligation or ring-closing metathesis. While solid-phase synthesis enables mass production, it requires expensive equipment and specialized materials. Liquid-phase synthesis is simpler but produces lower yields and impure peptides requiring separation.

 Market Dynamics:

Peptide synthesis has become one of the most important methodologies in bio-organic chemistry for research and diagnosis. Moreover, the incidence of infectious diseases such as malaria and others is expected to boost market growth. For instance, on August 21, 2023, according to the Centers for Disease Control and Prevention, the risk of malaria in the U.S. is very low. People do not spread malaria to other people, like the common cold or the flu. Also, malaria is not sexually transmitted. The U.S. reports about 2,000 cases of malaria each year. Most of these cases are in people traveling to areas where malaria spreads.

Furthermore, on February 10, 2023, according to the report published by the National Center for Biotechnology Information, every year, there are about 200 million cases of malaria globally, resulting in almost half a million deaths annually. Over 90% of all malaria deaths occur in sub-Saharan Africa. Children under the age of 5 are disproportionately affected by malaria. A child dies of malaria approximately every 2 minutes.

Key features of the study:

• This report provides in-depth analysis of the global peptide synthesis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peptide synthesis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, Biotage AB, AnaSpec, ABclonal, Inc. and Novelgene Technologies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market

Global Peptide Synthesis Market Detailed Segmentation:

• By Product
  • Reagents & Consumables
  • Equipment
    • Peptide Synthesizers
    • Lyophilizer
    • Chromatography Equipment
• By Technology
  • Solid Phase
  • Liquid Phase
  • Hybrid and Recombinant
• By Application
  • Therapeutics
    • Metabolic Disorders
    • Cardiovascular Disorders
    • Respiratory Disorders
    • Infectious Diseases
    • Others
  • Diagnosis
  • Research
• By End User
  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
  • Research Institutes
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Key Players
  • GenScript Biotech Corporation
  • Merck KGaA
  • ThermoFisher Scientific Inc.
  • Syngene
  • Lonza
  • Novo Nordisk A/S
  • Bachem Holding AG
  • Gyros Protein Technologies
  • Creative Diagnostics
  • CEM Corporation
  • PuroSynth
  • AAPPTec
  • Biotage AB
  • AnaSpec
  • ABclonal, Inc.
  • Novelgene Technologies